Diana Papaioannou

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 10

Top Topics

Stem Cell Transplantation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Papaioannou, Kirsty Sprange, Sienna Hamer-Kiwacz, Cara Mooney, Gwenllian Moody, Cindy Cooper
Recording harms in randomised controlled trials of behaviour change interventions: a qualitative study of UK clinical trials units and NIHR trial investigators. Trials 25 (1) (2024)
Diana Papaioannou, Kirsty Sprange, Sienna Hamer-Kiwacz, Cara Mooney, Gwenllian Moody, Cindy Cooper
Recording harms in randomised controlled trials of behaviour change interventions: a qualitative study of UK clinical trials units and NIHR trial investigators. Trials 25 (1) (2024)
Diana Papaioannou, Kirsty Sprange, Sienna Hamer-Kiwacz, Cara Mooney, Gwenllian Moody, Cindy Cooper
Recording harms in randomised controlled trials of behaviour change interventions: a qualitative study of UK clinical trials units and NIHR trial investigators. Trials 25 (1) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Diana Papaioannou, Kirsty Sprange, Sienna Hamer-Kiwacz, Cara Mooney, Gwenllian Moody, Cindy Cooper
Recording harms in randomised controlled trials of behaviour change interventions: a qualitative study of UK clinical trials units and NIHR trial investigators. Trials 25 (1) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)